continua IL black FRIDAY al CUBO |15% su tutto con il coupon 15alcubo | SCOPRI di più

Customer care
  • Paracetamol Marco Vitos 500mg 20 Tablets -35%

Paracetamol Marco Vitos 500mg 20 Tablets

3.06€ 4.70€
  • Purchase 3 items for 3.00€ each
  • Purchase 4 items for 2.94€ each
  • Purchase 5 items for 2.88€ each

Paracetamol Marco Viti 500mg

NAME

PARACETAMOLO MARCO VITI 500 MG COMPRESSED

PHARMACOTHERAPEUTIC CATEGORY

Analgesics and antipyretics, anilides.

ACTIVE PRINCIPLES

Each tablet contains: paracetamol 500 mg.

EXCIPIENTS

Magnesium stearate, cornstarch, povidone.

INDICATIONS

As an antipyretic: symptomatic treatment of febrile illnesses such as influenza, exanthematic diseases, acute respiratory tract affections, and so on. As an analgesic: headaches, neuralgia, myalgia and other painful manifestations of medium size, of varying origin.

CONTRAINDICATIONS / EFF.SECONDARI

Hypersensitivity to paracetamol or to any of the excipients.

DOSAGE

For children, it is imperative to observe the dose determined according to their body weight, and then choose the appropriate formulation. Approximate age based on body weight is indicated as information. In adults, the maximum oral dose is 3,000 mg of paracetamol per day. The physician must evaluate the need for treatments for more than 3 consecutive days. The dosage chart in relation to weight is the following. Children weighing between 26 and 40 kg (approximately 8 to 13 years): 1 tablet at a time, to be repeated if necessary after 6 hours, without exceeding 4 doses per day. Children weighing between 41 and 50 kg (approximately 12 to 15 years): 1 tablet at a time, to be repeated if necessary after 4 hours, without exceeding 6 doses per day. Children weighing over 50 kg (approximately 15 years): 1 tablet at a time, to be repeated if necessary after 4 hours, without exceeding 6 doses per day. Adults: 1 tablet at a time, to be repeated if necessary after 4 hours, without exceeding 6 doses per day. In case of severe pain or high fever, 2 500 mg tablets should be repeated if necessary within not less than 4 hours. Renal impairment: In case of severe renal impairment (creatinine clearance less than 10 ml / min), the interval between dosing should be at least 8 hours.

STORAGE

This medicine does not require any special storage conditions.

WARNINGS

In rare cases of allergic reactions, administration should be discontinued and adequate treatment should be instituted. Use caution in case of chronic alcoholism, excessive intake of alcohol (3 or more daily drinks per day), anorexia, bulimia or cachexia, chronic malnutrition (low liver glutathione reserves), dehydration, hypovolemia. Paracetamol should be administered with apathy caution with mild to moderate hepatocellular insufficiency (including Gilbert's syndrome), severe hepatic failure (Child-Pugh> 9), severe hepatic impairment, acute hepatitis, in combination with drugs that alter the function 'hepatic, lack of glucose-6-phosphate dehydrogenase, hemolytic anemia. High or prolonged doses of the product may cause severe kidney and blood disorders, so administration to subjects with renal impairment should only be performed if it is actually needed and under direct medical supervision. In the case of prolonged use it is advisable to monitor liver and kidney function and blood clot. During paracetamol treatment, before taking any other medication, check that it does not contain the same active ingredient, as paracetamol can be taken at high doses may result in severe adverse reactions. Invite the patient to contact your doctor before associating any other medicines.

INTERACTIONS

The oral absorption of paracetamol depends on the gastric emptying speed. Consequently, the concomitant administration of slowing drugs (eg anticholinergics, opioids) or increases (eg procinetics) the rate of gastric emptying can determine a decrease or increase in the bioavailability of the product respectively. Concomitant administration of cholestyramine reduces the absorption of paracetamol. The simultaneous intake of paracetamol and chloramphenicol may induce an increase in the chloramphenicol half-life, with the risk of elevating its toxicity. The paracetamol usoconcompulator with oral anticoagulants may induce slight variations in INR values. In these cases more frequent monitoring of INR values ​​should be conducted during concomitant use and after it is interrupted. Use with extreme caution and under strict control during chronic treatment with drugs that may induce liver monooxygenase induction or exposure to substances that may have such effects (eg rifampicin, cimetidine, antiepileptics such as glutethimide, phenobarbital, carbamazepine) . The same goes for cases of ethylisation and zidovudine treated patients. Paracetamol administration may interfere with the determination of uricemia (by means of the phosphophtungic acid method) and that of glucose (by the glucose oxidase-peroxidase method).

SIDE EFFECTS

Pathologies of the hemolipopoietic system: thrombocytopenia, leucopenia, anemia, agranulocytosis. Immune system disorders: hypersensitivity reactions (urticaria, laryngeal edema, angioedema, anaphylactic shock). Nervous system disorders: dizziness. Gastrointestinal disorders: gastrointestinal reaction. Hepatobiliary disorders: abnormal hepatic function, hepatitis. Skin and subcutaneous tissue disorders: multiforme erythema, Stevens Johnson syndrome, epidermal necrolysis, rash. Renal and urinary disorders: acute renal failure, interstitial nephritis, hematuria, anuria. Report unwanted effects directly via the national reporting system.

PREGNANCY AND BREASTFEEDING

Although clinical studies in pregnant or lactating patients have shown no particular contraindications to the use of paracetamol or its adverse effects on the mother or child, it is advisable to administer the product only in cases of actual need and under direct control of the doctor.

.